Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-08-25Clinical Trial Update: Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC [Phase 3]
Phase 3 clinical trial evaluating the efficacy, safety, and immunogenicity of CBT124 with EU-sourced Avastin (bevacizumab) in stage 4 non-sm…
-
CLINICAL_TRIALS research · 2016-08-09Clinical Trial Update: Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) [Phase 2]
Phase 2 neoadjuvant platinum-based chemotherapy for resectable non-small cell lung cancer with switch to an alternative chemotherapy regimen…
-
CLINICAL_TRIALS research · 2016-08-05Clinical Trial Update: Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC) [Phase 1]
A Phase 1 trial evaluating an RNActive-derived cancer vaccine with local radiation for stage IV non-small cell lung cancer has been terminat…
-
CLINICAL_TRIALS research · 2016-08-02Clinical Trial Update: Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer [NA]
Clinical trial evaluating palliative care teaching sessions for family caregivers of patients with non-small cell lung cancer has completed.…
-
CLINICAL_TRIALS research · 2016-07-29Clinical Trial Update: Immunotherapy With Racotumomab in Advanced Lung Cancer [Phase 3]
This clinical trial update reports on a Phase 3 study of racotumomab immunotherapy in advanced non-small cell lung cancer, sponsored by Reco…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-07-07Clinical Trial Update: A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations [Phase 3]
A Phase 3 clinical trial update studying gefitinib with or without apatinib in advanced non-squamous non-small cell lung cancer harboring EG…
-
CLINICAL_TRIALS research · 2016-07-04Clinical Trial Update: A Study of Prevalence of EGFR Mutations in Participants With NSCLC
This clinical trial update reports on the prevalence of EGFR mutations among participants with non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2016-07-04Clinical Trial Update: Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy
A clinical trial evaluating serum procalcitonin levels in patients with stage IV non-small cell lung cancer undergoing first-line chemothera…
-
CLINICAL_TRIALS research · 2016-06-30Clinical Trial Update: The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation [Phase 2]
This document reports a Phase 2 trial evaluating icotinib as perioperative therapy for EGFR-mutant stage IIIA-IIIB non-small cell lung cance…
-
CLINICAL_TRIALS research · 2016-06-29Clinical Trial Update: Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030
This update describes a cancer genome study using samples from patients with stage I–II non-small cell lung cancer who were treated on the A…
-
CLINICAL_TRIALS research · 2016-06-28Clinical Trial Update: Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202
This clinical trial update reports on tissue-sample analysis from patients with stage I non-small cell lung cancer enrolled in the CALGB-140…
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Acquired Resistant Mechanism of the First-generation EGFR TKIs
This clinical trial update discusses the acquired resistance mechanisms to first-generation EGFR tyrosine kinase inhibitors in non-small cel…
-
CLINICAL_TRIALS research · 2016-06-17Clinical Trial Update: A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
A multi-center prospective observational biomarker study in EGFR-mutant non-small cell lung cancer patients with leptomeningeal metastasis.
-
CLINICAL_TRIALS research · 2016-06-10Clinical Trial Update: Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment [NA]
An ongoing clinical trial is exploring markers of primary or acquired resistance to anticancer therapies in melanoma and lung cancers; curre…
-
CLINICAL_TRIALS research · 2016-06-03Clinical Trial Update: Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
This entry describes a Phase 3 clinical trial evaluating individualized adaptive radiotherapy guided by PET/CT and IMRT for locally advanced…
-
CLINICAL_TRIALS research · 2016-06-02Clinical Trial Update: A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy [Phase 2]
A Phase 2 clinical trial update evaluating hypofractionated radiotherapy for limited metastatic non-small cell lung cancer with EGFR-sensiti…
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients [Phase 3]
This Phase 3 trial investigates whether monosialoganglioside GM1 can prevent neurotoxicity caused by cisplatin-containing chemotherapy in no…
-
CLINICAL_TRIALS research · 2016-05-24Clinical Trial Update: Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf
This is an epidemiological study update describing management patterns for non-small cell lung cancer in the Middle East and North Africa, s…
-
CLINICAL_TRIALS research · 2016-05-23Clinical Trial Update: Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer [Phase 2, Phase 3]
This clinical trial update describes a study of apatinib in combination with docetaxel as second-line therapy for advanced non-squamous non-…
-
CLINICAL_TRIALS research · 2016-05-20Clinical Trial Update: Conmana Combined With Thalidomide to Treat NSCLC [Phase 4]
A Phase 4 clinical trial is evaluating Conmana in combination with thalidomide for non-small cell lung cancer, with the current status liste…
-
CLINICAL_TRIALS research · 2016-04-28Clinical Trial Update: The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase
This clinical-trial update reports on the evaluation of a lung cancer patient treated with an EGFR tyrosine kinase inhibitor, with the curre…
-
CLINICAL_TRIALS research · 2016-04-15Clinical Trial Update: Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer [NA]
A clinical trial comparing multiple-portal VATS versus uniportal VATS lobectomy for non-small cell lung cancer; the current study status is …
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: RT Plus EGFR-TKI for Wild-type NSCLC [Phase 2]
A Phase 2 clinical trial update examines using radiation therapy plus an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TK…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: Detection Cell Free DNA in Lung Cancer Patients
A clinical trial is evaluating the detection of cell-free DNA in patients with non-small cell lung cancer; the current status is unknown.
-
CLINICAL_TRIALS research · 2016-04-06Clinical Trial Update: Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating individual boosting in non-small cell lung cancer using hypofractionation,…